NCT06778772 Transition From Pediatric to Adult Epilepsy Care
| NCT ID | NCT06778772 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS National Neurological Institute "C. Mondino" Foundation |
| Condition | Epilepsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2025-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2023-06-01 with a primary completion date of 2025-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to assess the preparation of the caregiver and the patient for the transition, by comparing the results of the Transition Readiness Assessment (TRAQ) questionnaire at the time of the last pediatric neuropsychiatric visit, which is then repeated at the first adult epilepsy neurology visit. The assessments will be conducted at the last evaluation at the pediatric epilepsy service and repeated at the first visit to the adult epilepsy service.
Eligibility Criteria
\*\*Inclusion Criteria:\*\* * Patients aged 17 or 18 years. * Diagnosed with focal or generalized epilepsy, regardless of etiology and neuropsychological, neuropsychiatric, or internal comorbidities. * Those for whom continued epileptology follow-up is required according to standard care guidelines. \*\*Exclusion Criteria:\*\* * Patients undergoing EEG only for the detection of EEG abnormalities without a diagnosis of epilepsy. * Patients for whom the last neuropsychiatric evaluation does not recommend continued epileptology follow-up (patients considered "cured" from epilepsy according to ILAE guidelines).
Contact & Investigator
Valentina De Giorgis, MD
PRINCIPAL INVESTIGATOR
Child and Adolescent Epileptology
Frequently Asked Questions
Who can join the NCT06778772 clinical trial?
This trial is open to participants of all sexes, aged 17 Years or older, up to 18 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06778772 currently recruiting?
Yes, NCT06778772 is actively recruiting participants. Contact the research team at valentina.degiorgis@mondino.it for enrollment information.
Where is the NCT06778772 trial being conducted?
This trial is being conducted at Pavia, Italy.
Who is sponsoring the NCT06778772 clinical trial?
NCT06778772 is sponsored by IRCCS National Neurological Institute "C. Mondino" Foundation. The principal investigator is Valentina De Giorgis, MD at Child and Adolescent Epileptology. The trial plans to enroll 90 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.